Sentence examples for mortality for prostate from inspiring English sources

It has been claimed that decrease of mortality for prostate cancer is the major benefit of PSA-based screening.

Compared with the highest survival in Europe, avoidable mortality for prostate cancer rose in the early 1990s, but fell in the late 1990s.

Population-based screening for colorectal cancers was not widely available in Italy at the time of the study; therefore, it could not influence these trends, while drops in the mortality for prostate cancer since the mid-1980s are likely due to therapy advancements.

Regression coefficients recalculated after excluding stage 1 3 prostate cancer, stage 1 2 breast cancer, and stage 1 cervical cancer were not statistically significantly different from those presented in Table 3, although the rate ratio of the excess mortality for prostate cancer in the first month after diagnosis was reduced to 11.8 (95% confidence interval: 5.2 26.9).

Compared to men with a BRCA1 mutation, men with a BRCA2 mutation in this study were more than two times as likely to die (of any cause) following the diagnosis of prostate cancer (hazard ratio 2.5), and it is likely that the relative mortality for prostate cancer-specific mortality would be even more extreme.

In this study, the age-adjusted mortality for prostate cancer in the population exposed to the highest arsenic levels in the drinking water (≥0.60 ppm) was nearly 10-fold higher (9.18 deathan100,000) that that athehe lowest level (< 0.30 ppm; 0.95 deaths/100,000) of exposure.

Results may be different for other populations, as different incidences of and mortalities for prostate cancer have been observed in different countries (Ferlay et al, 2010).

The results may be different for other populations, as different incidences of and mortalities for prostate cancer have been observed in different countries (Ferlay et al, 2010).

Moreover, declines in mortality rates for prostate cancer have been affected also by chemotherapy with Docetaxel [ 25].

On the contrary, the mortality rate for prostate cancer (ASR-W: 11.5/100,000) in Serbia was similar to the European average.

These data were used to estimate prostate and breast cancer incidence and mortality rates for prostate cancer, breast cancer, and other causes.